Abstract
Results are presented on chromosome analyses made on 4,481 embryos or fetuses studied through chorionic villus sampling (CVS) in whom there was no known bias to presence of a chromosome abnormality except advanced parental age. We excluded from the analysis most cases in which mosaicism was diagnosed or in which there were cytogenetic discrepancies among samples obtained from the conceptus. There remain 48 cases of 47,+21, 39 cases of other nonlethal abnormalities, and 12 lethal abnormalities diagnosed in 4,481 studied. A regression analysis (restricted to the 3,848 cases diagnosed in the 35-49-year maternal age interval) was done on rates of (1) 47,+21, (2) other abnormalities excluding lethals or (3) including them, and (4) all abnormalities excluding lethals or (5) including them. The model used was y = exp(bx + c), where y is the rate of abnormality, x is maternal age at time of CVS (the modal age of the procedure was 10 gestational weeks from the last menstrual period), and b and c were, respectively, (1) 0.288 and -15.527; (2) 0.272 and -15.173; (3) 0.253 and -14.141; (4) 0.282 and -14.753; and (5) 0.271 and -14.195. We also derived rates of abnormalities at the time of CVS that would be predicted from rates (of nonmosaics) at amniocentesis after adjustment for the difference in gestational age between the usual times that these two procedures are done. The difference between the numbers of abnormalities predicted on the basis of these adjusted amniocentesis rates and the numbers observed at CVS provides an estimate of the spontaneous loss of embryos and fetuses between the usual gestational ages of these procedures. In these data, for 47,+21 the estimated proportion lost is 21% but the result is not significant at the .05 level. For other abnormalities excluding lethals the estimated spontaneous loss is 29% (P approximately .05); including lethals it is 44%. For all abnormalities, excluding lethals, pooled together, the estimate is 24%; including lethals it is 33%. The last three values are all significant at the .05 level or lower. The observed rates of abnormalities at CVS would be approximately 10% to 15% higher if one pooled diagnosed mosaics with the nonmosaics, but the estimated proportion of spontaneous fetal loss would be lower.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Ferguson-Smith M. A., Yates J. R. Maternal age specific rates for chromosome aberrations and factors influencing them: report of a collaborative european study on 52 965 amniocenteses. Prenat Diagn. 1984 Spring;4(Spec No):5–44. doi: 10.1002/pd.1970040704. [DOI] [PubMed] [Google Scholar]
- Hook E. B., Cross P. K. Rates of mutant and inherited structural cytogenetic abnormalities detected at amniocentesis: results on about 63,000 fetuses. Ann Hum Genet. 1987 Jan;51(Pt 1):27–55. doi: 10.1111/j.1469-1809.1987.tb00864.x. [DOI] [PubMed] [Google Scholar]
- Hook E. B., Cross P. K., Regal R. R. The frequency of 47,+21,47,+18, and 47,+13 at the uppermost extremes of maternal ages: results on 56,094 fetuses studied prenatally and comparisons with data on livebirths. Hum Genet. 1984;68(3):211–220. doi: 10.1007/BF00418391. [DOI] [PubMed] [Google Scholar]
- Hook E. B. Differences between rates of trisomy 21 (Down syndrome) and other chromosomal abnormalities diagnosed in livebirths and in cells cultured after second-trimester amniocentesis--suggested explanations and implications for genetic counseling and program planning. Birth Defects Orig Artic Ser. 1978;14(6C):249–267. [PubMed] [Google Scholar]
- Kajii T., Ohama K., Mikamo K. Anatomic and chromosomal anomalies in 944 induced abortuses. Hum Genet. 1978 Sep 19;43(3):247–258. doi: 10.1007/BF00278831. [DOI] [PubMed] [Google Scholar]
- Liddell F. D. Simple exact analysis of the standardised mortality ratio. J Epidemiol Community Health. 1984 Mar;38(1):85–88. doi: 10.1136/jech.38.1.85. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Schreinemachers D. M., Cross P. K., Hook E. B. Rates of trisomies 21, 18, 13 and other chromosome abnormalities in about 20 000 prenatal studies compared with estimated rates in live births. Hum Genet. 1982;61(4):318–324. doi: 10.1007/BF00276595. [DOI] [PubMed] [Google Scholar]